Mark John Smyth
Mark John Smyth publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Immune Cell Function and Interaction, Immunotherapy and Immune Responses and T-cell and B-cell Immunology.
- World rank
- #5,702 of 7,710,434 ranked researchers
- Rank in Australia
- #156 of 140,210
- Works
- 1,372
- Citations
- 122k
- Citations per work
- 88.8
What does Mark John Smyth research?
Mark John Smyth's work is mostly in Immunology and Microbiology (47%), Medicine (27%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences78156.9%
- Health Sciences37527.3%
- Medicine37527.3%
- Everything else21715.8%
- 1Immunology48% of their works
- 2Oncology20% of their works
- 3Molecular Biology9% of their works
- 4Hematology3% of their works
- 5Epidemiology2% of their works
- 6Radiology, Nuclear Medicine and Imaging2% of their works
Research topics
Which keywords describe Mark John Smyth's research?
The keywords of their largest research topics: Natural Killer Cells, NK Cell Recognition, Cancer Immunotherapy, Immunity, Antigen Presentation, Dendritic Cells, Foxp3 and TGF-ß.
- Cell Death
- Macrophage
- Therapeutic Antibodies
- PD-1 and PD-L1
- Chimeric Antigen Receptor
- TGF-ß
- Dendritic Cells
- Immunity
- Natural Killer Cells
- NK Cell Recognition
- Cancer Immunotherapy
- Antigen Presentation
- Foxp3
- CAR T Cells
- Immune Checkpoint Blockade
- Fc Receptors
- Activation
- Apoptosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- NK Cell Recognition4171 topic
- Natural Killer Cells4171 topic
- Cancer Immunotherapy3702 topics
- Immunity2502 topics
- Antigen Presentation2071 topic
- Dendritic Cells2071 topic
- Foxp32071 topic
- TGF-ß2071 topic
- CAR T Cells1631 topic
- Chimeric Antigen Receptor1631 topic
- Immune Checkpoint Blockade1351 topic
- PD-1 and PD-L11351 topic
- Fc Receptors491 topic
- Therapeutic Antibodies491 topic
- Activation431 topic
- Macrophage431 topic
- Apoptosis421 topic
- Cell Death421 topic
Where does Mark John Smyth work?
Mark John Smyth's main affiliation in the publication record is Peter MacCallum Cancer Centre, Australia.
How many publications and citations does Mark John Smyth have?
OpenAlex counts 1,372 works and 121,881 citations for Mark John Smyth, an h-index of 173, ranking #5,702 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark John Smyth. Posts are plain text and can be reported.